Fora Capital, LLC Vertex Pharmaceuticals Inc Transaction History

Fora Capital, LLC

$789 Million
Q3 2024

A detailed history of Fora Capital, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Fora Capital, LLC holds 9,402 shares of VRTX stock, worth $3.74 Million. This represents 0.55% of its overall portfolio holdings.

Number of Shares

9,402

Previous 8,173 15.04%

Holding current value

$3.74 Million

Previous $3.83 Million 14.15%

% of portfolio

0.55%

Previous 0.48%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$460.0 - $505.78 $565,340 - $621,603	1,229 Added 15.04%	9,402 $4.37 Million
Q2 2024 Aug 13, 2024	BUY	$392.81 - $485.53 $1.31 Million - $1.62 Million	3,329 Added 68.72%	8,173 $3.83 Million
Q1 2024 May 02, 2024	BUY	$407.69 - $446.08 $1.97 Million - $2.16 Million	4,844 New	4,844 $2.02 Million
Q3 2023 Nov 13, 2023	BUY	$338.18 - $362.46 $3.81 Million - $4.08 Million	11,257 Added 286.29%	15,189 $5.28 Million
Q2 2023 Aug 11, 2023	BUY	$314.42 - $351.91 $1.24 Million - $1.38 Million	3,932 New	3,932 $1.38 Million
Q1 2022 May 12, 2022	SELL	$221.42 - $260.97 $1.31 Million - $1.54 Million	-5,909 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$177.01 - $223.45 $3,009 - $3,798	-17 Reduced 0.29%	5,909 $1.3 Million
Q3 2021 Nov 15, 2021	BUY	$181.39 - $202.99 $1.07 Million - $1.2 Million	5,926 New	5,926 $1.08 Million
Q2 2021 Aug 16, 2021	SELL	$187.49 - $221.1 $779,395 - $919,112	-4,157 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$207.02 - $241.31 $860,582 - $1 Million	4,157 New	4,157 $893 Million
Q2 2020 Aug 14, 2020	SELL	$225.48 - $295.8 $843,520 - $1.11 Million	-3,741 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$199.77 - $247.81 $1.65 Million - $2.05 Million	-8,253 Reduced 68.81%	3,741 $890,000
Q4 2019 Feb 14, 2020	BUY	$166.71 - $223.91 $2 Million - $2.69 Million	11,994 New	11,994 $2.63 Million

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $102B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fora Capital, LLC with notifications on news.

Account